U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Lipoxygenase Inhibitors [Pharmacological Action]

Tree Number(s): D016859

MeSH Unique ID: D016859

  • benoxaprofen (Supplementary Concept)
  • phenidone (Supplementary Concept)
  • nafazatrom (Supplementary Concept)
  • azelastine (Supplementary Concept)
  • 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid (Supplementary Concept)
  • piriprost (Supplementary Concept)
  • 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (Supplementary Concept)
  • 9-hydroperoxy-11,12-octadecadienoic acid (Supplementary Concept)
  • alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol (Supplementary Concept)
  • 4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one (Supplementary Concept)
  • Wy 45911 (Supplementary Concept)
  • N-(3-phenoxycinnamyl)acetohydroxamic acid (Supplementary Concept)
  • 5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate (Supplementary Concept)
  • MK-886 (Supplementary Concept)
  • LY 178002 (Supplementary Concept)
  • oxphaman (Supplementary Concept)
  • zileuton (Supplementary Concept)
  • 3-(5-hydroxy-4,6,7-trimethyl-1,3-benzoxathiazol-2-yl)propanol (Supplementary Concept)
  • S(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid (Supplementary Concept)
  • N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide (Supplementary Concept)
  • L 670630 (Supplementary Concept)
  • N-linoleoyldopamine (Supplementary Concept)
  • chebulagic acid (Supplementary Concept)
  • 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid (Supplementary Concept)
  • camelliaside C (Supplementary Concept)
  • 2',5'-dimethoxy-3,4-dihydroxychalcone (Supplementary Concept)
  • licofelone (Supplementary Concept)
  • N-hydroxy-N-(1-(2-phenyl-5-benzofuranyl)ethyl)furancarboxamide (Supplementary Concept)
  • 5-(N-hydroxy-N-(1-(2-(3,4,5-trimethoxyphenyl)-5-benzofuranyl)ethyl)amino)-5-oxopentanoate (Supplementary Concept)
  • N-hydroxy-N-(1-(2-phenylbenzofuran-5-yl)ethyl)urea (Supplementary Concept)
  • atreleuton (Supplementary Concept)
  • 1-phenylperhydro-1,2,4-triazin-3-one (Supplementary Concept)
  • L 708780 (Supplementary Concept)
  • CMI 392 (Supplementary Concept)
  • 4-(2-oxapentadeca-4-yne)phenylpropanoic acid (Supplementary Concept)
  • ((E)-(5)-(3,5-di-tert-butyl-4-hydroxybenzylidene)- 2-ethyl-1,2-isothiazolidine-1,1-dioxide) (Supplementary Concept)
  • ocobullenone (Supplementary Concept)
  • 3-oxo-tirucall-8,24-dien-21-oic acid (Supplementary Concept)
  • 1,6-dimethyl-2-(4'-N-n-propylsuccinamido)methyl-3-hydroxypyridin-4(1H)-one (Supplementary Concept)
  • N-4-(4-methoxyphenylaminosulfonyl)benzoisoselenothiazolidone (Supplementary Concept)
  • N-4-(4-fluorophenylaminosulfonyl)benzoisoselenothiazolidone (Supplementary Concept)
  • 4-(5-fluoro-3-(4-(2-methyl-1H-imidazol-1-yl)benzyloxy)phenyl)-3,4,5,6-tetrahydro-2H-pyran-4-carboxamide (Supplementary Concept)
  • 4-(5-fluoro-3-(4-(2-methyl-1H-imidazol-1-yl)benzyloxy)phenyl)-4-methoxy-3,4,5,6-tetrahydro-2H-pyran (Supplementary Concept)
  • tetrapetalone B (Supplementary Concept)
  • tetrapetalone C (Supplementary Concept)
  • tetrapetalone D (Supplementary Concept)
  • S 29606 (Supplementary Concept)
  • S 30621 (Supplementary Concept)
  • 5-Loxin (Supplementary Concept)
  • 12-labdene-15,16,(8)17-trial (Supplementary Concept)
  • 2-(4-hydroxyphenyl)-3-(3,5-dihydroxyphenyl)propenoic acid (Supplementary Concept)
  • 2-(4-aminophenyl)-3-(3,5-dihydroxylphenyl)propenoic acid (Supplementary Concept)
  • LQFM-091 (Supplementary Concept)
  • Diethylcarbamazine (MeSH Term)
  • Masoprocol (MeSH Term)
  • 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine (MeSH Term)

Supplemental Content

Loading ...